| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |